Cardiol Therapeutics Inc. (CRDL) is a clinical-stage biotechnology company headquartered in Oakville, Canada, focusing on the development of innovative anti-inflammatory therapies for cardiovascular diseases (CVD). With a strong pipeline supported by advanced research and development efforts, the company is committed to addressing pressing unmet medical needs in CVD treatment. By harnessing leading-edge science and expertise in inflammation, Cardiol Therapeutics aims to deliver novel therapeutic solutions that have the potential to significantly improve patient outcomes globally.
Click "Analyze" to generate stock analysis
CRDL Price Trend and Signals
CRDL Option Volumes & Open Interests (aggregated)
CRDL Put Call Ratios and IV (aggregated)
CRDL Financials
2025-10-27Somewhat Bullishprice_signal
Monthly high detected.
2025-10-21Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.